Results 71 to 80 of about 2,137 (167)
Genetically Engineered Microorganisms and Their Impact on Human Health
International Journal of Clinical Practice, Volume 2024, Issue 1, 2024.The emergence of antibiotic‐resistant strains, the decreased effectiveness of conventional therapies, and the side effects have led researchers to seek a safer, more cost‐effective, patient‐friendly, and effective method that does not develop antibiotic resistance.Marzie Mahdizade Ari, Leila Dadgar, Zahra Elahi, Roya Ghanavati, Behrouz Taheri, Marta Laranjo +5 morewiley +1 more sourceEuropean consensus conference on faecal microbiota transplantation in clinical practice [PDF]
, 2017 Faecal microbiota transplantation (FMT) is an important therapeutic option for Clostridium difficile infection. Promising findings suggest that FMT may play a role also in the management of other disorders associated with the alteration of gut microbiota.Aloi, Marina, Arkkila, Perttu, Cammarota, Giovanni, De Groot, Pieter, de Vos, Willem M., European FMT Working Grp, Gasbarrini, Antonio, Gasbarrini, Giovanni, Hart, Ailsa, Hoegenauer, Christoph, Ianiro, Gianluca, Kump, Patrizia, Link, Alexander, Lopez-Sanroman, Antonio, Malfertheiner, Peter, Masucci, Luca, Mattila, Eero, Milosavljevic, Tomica, Molinaro, Antonio, Nieuwdorp, Max, Pintus, Cristina, Rajilic-Stojanovic, Mirjana, Sanguinetti, Maurizio, Satokari, Reetta, Scaldaferri, Franco, Segal, Jonathan, Simren, Magnus, Sokol, Harry, Tilg, Herbert +28 morecore +2 more sourcesClostridium difficile infection. [PDF]
, 2016 Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life threatening, especially in elderly people and in patients who have dysbiosis of the gut microbiota following antimicrobial drug exposure. C.A Antunes, A Bergstrom, A Collignon, A Goorhuis, A Greco, A Kovacs-Simon, A Olling, A Olling, A Ryan, A Shen, A Shen, A Spina, A Sundriyal, A Tasteyre, AC Clements, AM King, AP Roberts, AR Levy, B Dupuy, B Dupuy, B Schorch, BG Mitchell, BG Stare, C Darkoh, C Deneve, C Eckert, C Goncalves, C Janoir, C Lanzas, C Schwan, C Slimings, CA Cowardin, CA Nadon, CE Martin, CG Buffie, CH Chilton, CJ Donskey, CM Surawicz, CM Theriot, CM Theriot, CN Abou Chakra, CP Kelly, CR Clabots, CR Polage, CS Kwok, CW Knetsch, CW Knetsch, CW Knetsch, CW Knetsch, D Bhattacharjee, D Drudy, D Gebhart, D Lyras, D Paredes-Sabja, D Paredes-Sabja, D Paredes-Sabja, DA Burns, DA Enoch, DA Leffler, DA Rasko, DM Lyerly, DN Gerding, DN Gerding, DS Metcalf, DW Eyre, DW Eyre, E Bordeleau, E Reigadas, E van Nood, E Zimlichman, EB Purcell, EG McDonald, EG Semenyuk, EJ Kuijper, EL Best, EO Petrof, ER Dubberke, F Ammam, F Barbut, FC Lessa, FC Tenover, FU Battistuzzi, G Dobson, G Triadafilopoulos, GA Brito, GA Hammond, GE Schutze, GO Androga, GP Carter, GP Carter, GS Crowther, GS Crowther, H Kandalaft, H Pituch, H Sokol, H Yu, I El Meouche, I Just, I Just, I Lowy, I Youngster, I Zollner-Schwetz, IA Tickler, IC Hall, IM Tleyjeh, IM Zacharioudakis, J Amy, J Freeman, J Freeman, J Leibowitz, J Peltier, J Peltier, J Steele, J Tam, JA Leeds, JA Sorg, JG Bartlett, JG Bartlett, JH Kwon, JK Shim, JM Lanis, JM Suarez, JZ Goldenberg, K Eastwood, KA Davies, KA Fimlaid, KE Mackin, KE Rosenbusch, KO Bender, KR Hargreaves, KR Reveles, KS Tan, KV Ota, L Bouillaut, L Gabriel, L Kyne, L Novack, L Tulli, LE Bruijnesteijn van Coppenraet, LH Hansen, LH Slater, LJ Deakin, LJ Pettit, LM Feazel, M Bouwknegt, M Egerer, M Furuichi, M Hasegawa, M He, M Merrigan, M Monot, M Riegler, M Sauerborn, M Sebaihia, M Tvede, M Warny, MA Farrow, MA Le, MC Abt, MC Rea, MD Neal, MD Zilberberg, ME LaFrance, MH Samore, MH Wilcox, MH Wilcox, MJ Aldape, MJ Hopkins, MJ Martin, ML Hutton, MM Awad, MM Merrigan, MM Riggs, MP Bauer, MP Bauer, MP Hensgens, MP Hensgens, MP Hensgens, MP Hensgens, MS Brouwer, N Mani, N Mani, N Minton, N Nanwa, N Terada, N Yutin, NM Chumbler, OA Cornely, OA Cornely, P Papatheodorou, P Papatheodorou, P Spigaglia, P Spigaglia, P Spigaglia, P Yuan, PD Ziakas, PJ Bingley, PK Kump, PM Chong, PN Wiegand, R Baldan, R Govind, R McQuade, RB D'Agostino Sr, RN Pruitt, RN Pruitt, RP Vonberg, RP Vonberg, RU Varier, RW McKee, S Borgmann, S Genisyuerek, S Hafiz, S Johnson, S Karlsson, S Karlsson, S Perelle, SA Kuehne, SA Kuehne, SA Kuehne, SB Debast, SD Baines, SD Baines, SH Cohen, SJ Dancer, SK Lim, SM McBride, SM Smith, SN Faust, SR Curry, SS Dineen, SS Ghantoji, T Dapa, T Giesemann, T Lynch, T Murase, T Planche, TC Hing, TC Savidge, TC Savidge, TD Ho, TD Ho, TD Lawley, TD Lawley, TD Planche, TJ Louie, TJ Louie, TJ Mitchell, V Braun, VG Loo, WK Smits, WN Fawley, X Na, X Sun, Y Yoshino, YP Lin +255 morecore +1 more sourceEffect of the Synthetic Bile Salt Analog CamSA on the Hamster Model of Clostridium difficile Infection
, 2018 Clostridium difficile infection (CDI) is the leading cause of antibiotic-associated diarrhea and has gained worldwide notoriety due to emerging hypervirulent strains and the high incidence of recurrence. We previously reported protection of mice from CDI Abel-Santos, Ernesto, Estrada, Alan, Hedlund, Brian P., Howerton, Amber, Liao, Zhenlin, Mefferd, Chrisabelle C., Murugapiran, Senthil K., Phan, Jacqueline R., Seymour, Cale O., Wagner, Adam J. +9 morecore +1 more sourcePara-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria [PDF]
, 2018 Clostridium difficile is a Gram-positive spore-forming anaerobe and a major cause of antibiotic-associated diarrhoea. Disruption of the commensal microbiota, such as through treatment with broad-spectrum antibiotics, is a critical precursor for ...Baines, Simon D, Bianconi, Irene, Cutting, Simon M, Dawson, Lisa F, Harrison, Mark A, Hong, Huynh A, Kaur, Harparkash, Letertre, Marine P M, Nasher, Fauzy, Passmore, Ian J, Preston, Mark D, Swann, Jonathan R, Wren, Brendan W +12 morecore +6 more sourcesHuman Intestinal Cells Modulate Conjugational Transfer of Multidrug Resistance Plasmids between Clinical Escherichia coli Isolates. [PDF]
, 2014 Bacterial conjugation in the human gut microbiota is believed to play a major role in the dissemination of antibiotic resistance genes and virulence plasmids.A Darfeuille-Michaud, A Khoruts, A Smet, AE Franke, Ana Manuel Dantas Machado, AS Neish, B Stecher, B Stecher, BD Muegge, C Kunz, C Lupp, C Moubareck, CH Lester, Dipshikha Chakravortty, E Karra, EA Wadolkowski, EL Tatum, F Baquero, G Dantas, G Eisenhofer, JA Heinemann, JB Daniels, JL Round, K Chiller, L Morelli, LK Poulsen, M Kasuya, M Roberts, M Trobos, MA McConnell, MOA Sommer, MOA Sommer, Morten O. A. Sommer, MW Hull, RE Ley, S Bates, S Faure, S Halary, SE Winter, T Pédron, TR Licht, TR Licht, V Burrus, WB Whitman +43 morecore +4 more sourcesGut microbiota analysis reveals a marked shift to bifidobacteria by a starter infant formula containing a synbiotic of bovine milk-derived oligosaccharides and Bifidobacterium animalis subsp. lactis CNCM I-3446. [PDF]
, 2016 Non-digestible milk oligosaccharides were proposed as receptor decoys for pathogens and as nutrients for beneficial gut commensals like bifidobacteria.Bartoli, J-M., Berger, Bernard, Blaut, Michael, Borszewska-Kornacka, M., Brevaut-Malaty, V., Brussow, Harald, Feleszko, W., François, P., Gire, C., Grathwohl, Dominik, Junick, Jana, Leclaire, M., Maurin, J-M., Pecquet, Sophie, Rezzonico, Enea, Schmidt, S., Simeoni, Umberto, Skorka, A., Sprenger, Norbert, Squizzaro, C., Szajewska, Hania, Team, Study, Verdot, J-J. +22 morecore +3 more sourcesDysbiosis of the gut microbiota in disease [PDF]
, 2015 There is growing evidence that dysbiosis of the gut microbiota is associated with the pathogenesis of both
intestinal and extra-intestinal disorders. Intestinal disorders include inflammatory bowel disease, irritable
bowel syndrome (IBS), and coeliac ...Carding, S, Corfe, BM, Owen, LJ, Verbeke, K, Vipond, DT +4 morecore +3 more sources